LOW-DENSITY LIPOPROTEIN CHOLESTEROL CONTROL AND RATES OF CARDIOVASCULAR EVENTS OVER TIME IN MYOCARDIAL INFARCTION PATIENTS TREATED WITH LIPID-LOWERING THERAPY IN THE UNITED KINGDOM

被引：0
|
作者：
Beaini, Y. [1 ,2 ,3 ]
Danese, M. [4 ]
Sidelnikov, E. [5 ]
Villa, G. [5 ]
Catterick, D. [6 ]
Iqbal, M. [6 ]
Gleeson, M. [4 ]
Lubeck, D. [4 ]
Patel, J. [7 ]
机构：
[1] Bradford & Airedale CCG, Bradford, W Yorkshire, England
[2] West Yorkshire Hlth Care Partnership NHS, Bradford, W Yorkshire, England
[3] Univ Bradford, Bradford, W Yorkshire, England
[4] Outcomes Insights Inc, Agoura Hills, CA USA
[5] Amgen Europe GmbH, Rotkreuz, Switzerland
[6] Amgen Ltd, Uxbridge, Middx, England
[7] Sandwell & West Birmingham Hosp NHS Trust, Birmingham, W Midlands, England
来源：
VALUE IN HEALTH | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCV64
引用
收藏
页码：S498 / S498
页数：1
相关论文
共 50 条
  • [31] Incidence of new atherothrombotic brain infarction in older persons with prior myocardial infarction and serum low-density lipoprotein cholesterol ≥125 mg/dl treated with statins versus no lipid-lowering drug
    Aronow, WS
    Ahn, C
    Gutstein, H
    JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2002, 57 (05): : M333 - M335
  • [32] Impact of an Intensive Lipid-Lowering Therapy Protocol on Achieving Target Low-Density Lipoprotein Cholesterol Levels in Patients With Acute Coronary Syndrome
    Seiyama, Kosuke
    Oka, Akihiro
    Miyoshi, Toru
    Sudo, Yuya
    Takagi, Wataru
    Ugawa, Satoko
    Okada, Tomoaki
    Nosaka, Kazumasa
    Doi, Masayuki
    CIRCULATION REPORTS, 2025, 7 (02) : 131 - 138
  • [33] Lost Therapeutic Benefit of Delayed Low-Density Lipoprotein Cholesterol Control in Statin-Treated Patients and Cost-Effectiveness Analysis of Lipid-Lowering Intensification
    Marquina, Clara
    Morton, Jedidiah
    Zomer, Ella
    Talic, Stella
    Lybrand, Sean
    Thomson, David
    Liew, Danny
    Ademi, Zanfina
    VALUE IN HEALTH, 2023, 26 (04) : 498 - 507
  • [34] Low-Density Lipoprotein Cholesterol-Lowering Therapy for Atherosclerotic Cardiovascular Disease in the Future
    Abe, Shichiro
    Nishino, Setus
    Kanaya, Tomoaki
    Sakuma, Masashi
    Toyoda, Shigeru
    AMERICAN JOURNAL OF CARDIOLOGY, 2024, 215
  • [35] LIPID-LOWERING THERAPY IN DIFFERENT REGIONS OF THE UNITED STATES: INSIGHTS FROM GETTING TO AN IMPROVED UNDERSTANDING OF LOW-DENSITY LIPOPROTEIN CHOLESTEROL AND DYSLIPIDEMIA MANAGEMENT (GOULD): A REGISTRY OF HIGH CARDIOVASCULAR RISK PATIENTS IN THE UNITED STATES
    Ballantyne, Christie M.
    Cannon, Christopher
    de Lemos, James
    Rosenson, Robert
    Philip, Kiran
    Mues, Katherine
    Alam, Shusama
    Liu, Yuyin
    Bhatt, Deepak L.
    Kosiborod, Mikhail
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 1834 - 1834
  • [36] Trends in low-density lipoprotein cholesterol goal achievement and changes in lipid-lowering therapy after incident atherosclerotic cardiovascular disease: Danish cohort study
    Ersboll, Annette Kjaer
    Kristensen, Marie Skov
    Nybo, Mads
    Hede, Simone Moller
    Mikkelsen, Kristian Handberg
    Gislason, Gunnar
    Lytken Larsen, Mogens
    Green, Anders
    PLOS ONE, 2023, 18 (05):
  • [37] Frequency of congestive heart failure in older persons with prior myocardial infarction and serum low-density lipoprotein cholesterol ≥125 mg/dl treated with statins versus no lipid-lowering drug
    Aronow, WS
    Ahn, C
    AMERICAN JOURNAL OF CARDIOLOGY, 2002, 90 (02): : 147 - +
  • [38] Low-density lipoprotein cholesterol lowering for the prevention of cardiovascular outcomes in patients with ischemic stroke
    Ntaios, George
    Milionis, Haralampos
    INTERNATIONAL JOURNAL OF STROKE, 2019, 14 (05) : 476 - 482
  • [39] Low-density lipoprotein cholesterol lowering in real-world patients treated with evolocumab
    Desai, Nihar R.
    Wade, Rolin L.
    Xiang, Pin
    Pinto, Lionel
    Nunna, Sasikiran
    Wang, Xin
    Exter, Jason
    Mues, Katherine E.
    Habib, Mohdhar
    Chen, Chi-Chang
    CLINICAL CARDIOLOGY, 2021, 44 (05) : 715 - 722
  • [40] TOTAL AND LOW-DENSITY LIPOPROTEIN CHOLESTEROL LEVELS IN HIGH RISK PATIENTS TREATED WITH ATORVASTATIN MONOTHERAPY IN THE UNITED KINGDOM
    Jameson, K.
    D'Oca, K.
    Zhao, C.
    Ramey, D.
    Tershakovec, A. M.
    Marrett, E.
    VALUE IN HEALTH, 2013, 16 (07) : A514 - A514
12345